Jesse Shefferman - Jan 3, 2024 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
CEO and President, Director
Signature
/s/ Mary Grendell, Attorney-In-Fact
Stock symbol
TARA
Transactions as of
Jan 3, 2024
Transactions value $
-$12,673
Form type
4
Date filed
1/5/2024, 04:30 PM
Previous filing
Jun 27, 2023
Next filing
Jan 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Tax liability -$12.7K -5.84K -0.65% $2.17 899K Jan 3, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022.